Skip to main content
Clinical Trials/ACTRN12611000916943
ACTRN12611000916943
Terminated
未知

Multicentre randomised controlled trial in preterm infants 25-28 weeks gestation on continuous positive airway pressure of the effect of minimally-invasive surfactant therapy in comparison to standard care (continuation of CPAP) on the incidence of the composite outcome of death or physiological BPD.

Menzies Institute of Medical Research University of Tasamania0 sites486 target enrollmentAugust 26, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Menzies Institute of Medical Research University of Tasamania
Enrollment
486
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 26, 2011
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Menzies Institute of Medical Research University of Tasamania

Eligibility Criteria

Inclusion Criteria

  • 1\. Gestational age 25\-28 completed weeks 2\. Requiring CPAP with signs of early respiratory distress. 3\. CPAP pressure of 5\-8 cm H2O and FiO2 \>\=0\.30\. 4\. Less than 6 hours of age. 5\. Agreement of the Treating Physician in charge of the infant’s care. 6\. Signed parental consent.

Exclusion Criteria

  • 1\. Previously intubated, or in imminent need of intubation because of respiratory distress, apnoea or persistent acidosis.
  • 2\. Congenital anomaly or condition that might adversely affect breathing.
  • 3\. Identifiable alternative cause for respiratory distress (e.g. congenital pneumonia or pulmonary hypoplasia).
  • 4\. Lack of availability of an OPTIMIST treatment team.

Outcomes

Primary Outcomes

Not specified

Similar Trials